The Access to Medicine Index
The Access to Medicine Index is an initiative supported by 30 institutional investors holding $3.7 trillion in assets under management, designed to help inform pharmaceutical companies, investors, governments, academics, non-governmental organisations and wider society with independent, impartial and reliable information on individual pharmaceutical companies’ efforts to improve global access to medicines. Access to medicine is a basic social and cultural right, yet each year millions of people die due to preventable and treatable diseases, whilst others suffer due to neglected diseases that could be eliminated if only poor communities had ready access to medicine. The Investor Statement acknowledges the important role pharmaceutical companies can play in affording access to medicine, and calls upon all players in the sector fully to disclose the risks and opportunities that can build value and enhance reputation over time.
We are members of ClimateWise and UKSIF.